Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

Mostrar otras versiones (1)

INTRODUCTION: The longitudinal responses towards multiple doses of COVID-19 mRNA vaccines in patients with systemic autoimmune diseases remain incompletely understood. While observational studies suggested the safety of COVID-19 mRNA vaccines in rheumatic disease patients, laboratory evidence is lac...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Zesheng, Figueroa-Parra, Gabriel, Zhou, Xian, Li, Yanfeng, Jaquith, Jane, McCarthy-Fruin, Kathleen, Sletten, Jennifer, Warrington, Kenneth J., Weyand, Cornelia, Crowson, Cynthia S., Chumsri, Saranya, Knutson, Keith L., Sanchez-Rodriguez, Alain, Thanarajasingam, Uma, Duarte-García, Alí, Zeng, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424846/
https://www.ncbi.nlm.nih.gov/pubmed/37583697
http://dx.doi.org/10.3389/fimmu.2023.1224702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424846/
https://www.ncbi.nlm.nih.gov/pubmed/37583697
http://dx.doi.org/10.3389/fimmu.2023.1224702

Ejemplares similares